A senior doctor in regional South Australia has become the first Australian to receive the AstraZeneca COVID-19 vaccine.
- 300,000 doses of the AstraZeneca vaccine arrived in Australia this week
- Frontline workers in the SA town of Murray Bridge are first to receive the jab
- The vaccine has been approved, as safe, through rigorous testing processes
Caroline Phegan, a GP consultant and head of the Riverland Mallee Coorong Local Health Network, received the jab at Murray Bridge Hospital this morning.
Dr Phegan said she was immunocompromised, and would therefore be especially vulnerable to the coronavirus.
She said she was excited to receive the inoculation and honoured to be the first in the country.
“I feel very privileged and very honoured to be the first person in Australia to receive it, and I hope I reassure people that it is a safe vaccine.” Dr Phegan said.
Dozens of fellow medical staff will receive the jab this week.
‘Very important program for our nation’
South Australian Premier Steven Marshall said it was a special day that the state should celebrate.
“We know that this is a very important program for our nation [and] we are super pleased in South Australia to be the first place in the nation,” Mr Marshall said.
“1,000 doses were received yesterday and within 36 hours of this vaccine being received into South Australia, we’re already starting the rollout.
AstraZeneca was the second COVID-19 vaccine to be given the green light in Australia, after the Pfizer vaccine.
South Australia’s Chief Public Health Officer Nicola Spurrier stressed that both vaccines had been shown to be safe and effective.
“I really want to make it clear to everybody that they are equally effective and safe,” Professor Spurrier said.
“As a healthcare worker myself, I don’t care which vaccine that I get.
“We are so lucky that we have got two safe and effective vaccines here in Australia.”
Australia’s Therapeutic Goods Administration (TGA) approved the AstraZeneca vaccine after a rigorous testing process last month.
The TGA said it had been shown to be safe and to prevent COVID-19 but it was not clear yet whether it prevented transmission of asymptomatic disease.
Most experts have backed its approval, despite some concerns over the strength of scientific data, as rollouts and new trials of the vaccine continue overseas.